Product

BNT142

1 clinical trial

1 indication

Indication

Clinical trial

First-in-human, Open-label, Multicenter, Phase I/IIa, Dose Escalation Trial With Expansion Cohorts to Evaluate Safety and Preliminary Efficacy of BNT142 in Patients With CLDN6-positive Advanced Solid Tumors

Status: Recruiting, Estimated PCD: 2025-10-01